HEFUU in Almedalen: Should we pay more for medication for more seriously ill patients?
Bildtext
Allocation of health care resources with a view to create the greatest possible health fails to take into account how health gains are distributed among individuals. The ethical platform that governs priorities pits disease severity and cost-effectiveness against each other. How should the balance be made?
On June 28, 2024, Prof. Erik Grönqvist (Uppsala University), director at the Center for Health Economics Research (HEFUU) and university lecturer Sophie Langenskiöld, HEFUU, hosted a seminar in Almedalen.
At the seminar, preliminary results from a study detailing how the population wants disease severity to be weighed against cost-effectiveness when making priorities were presented.
A panel discussed how the balance should be made and whether the population's assessment should have an influence on decision-making. Points of discussion included which ethical principles should guide prioritisation of healthcare resources and how these should be weighed against each other. The panel also discussed how the corresponding balance is made in other countries.
When asked whether we should pay more for medication for more seriously ill patients, each panel member gave a positive answer, though opinions varied as to what extent and why.
Additional participants on the panel were Karolina Antonov, acting CEO and Head of Analysis (Lif), Niklas Juth, Professor of Medical Ethics (Uppsala University), Douglas Lundin, Chief Economist (TLV).
If you missed the broadcast or wish to see it again:
https://live.mediaflow.com/65CBF0IV0G
Länkar
Ta bort länkrutan helt om den inte behövs.